Global Biodegradable Stents Market Size By Type (Polymer Based Bioabsorbable Stents, Metal Based Bioabsorbable Stents), By Application (Coronary Artery Disease, Peripheral Artery Disease), By Region,...

The Global Biodegradable Stents Market was valued at USD 412 million in 2023 and is projected to reach USD 1,030 million by 2031, growing at a CAGR of 12.2% during the forecast period from 2023 to 2031. Biodegradable stents, also known as bioresorbable or resorbable stents, are revolutionizing cardiovascular and peripheral interventions by eliminating the need for permanent implants. The growing prevalence of cardiovascular diseases (CVDs), increased adoption of minimally invasive procedures, and the limitations associated with traditional metallic stents are driving the global market forward.

The market is experiencing heightened demand due to the increasing aging population, rising awareness about post-surgery complications from permanent implants, and ongoing advancements in polymer science and bioengineering. As clinical trials continue to validate the safety and efficacy of next-generation stents, the adoption of biodegradable alternatives is expected to rise across healthcare systems worldwide.

Drivers:

1. Rising Incidence of Cardiovascular Diseases (CVDs):

The increasing global burden of CVDs, particularly coronary artery disease (CAD), is a primary driver for biodegradable stents. With CVDs accounting for nearly 18 million deaths annually, the demand for safe and effective treatment options has intensified.

2. Shift Toward Minimally Invasive Procedures:

Surging preference for less invasive surgical options has contributed significantly to the adoption of bioresorbable stents, which require fewer follow-up procedures and reduce long-term risks compared to traditional metal stents.

3. Technological Advancements in Biomaterials:

Breakthroughs in polymer-based and magnesium alloy-based stents are improving the mechanical strength, biocompatibility, and degradation timelines of biodegradable stents, enhancing clinical outcomes.

Restraints:

1. High Costs and Limited Reimbursement:

The relatively higher price of biodegradable stents and inconsistent reimbursement policies in developing countries may hinder market penetration, especially for patients with limited financial access.

2. Clinical Performance Concerns:

Despite promising advancements, early-generation stents faced setbacks due to issues like late thrombosis and slow resorption. While newer models are addressing these, ongoing skepticism among practitioners persists.

Opportunity:

1. Growth in Emerging Markets:

Rapid healthcare infrastructure development in Asia-Pacific and Latin America offers a significant opportunity for market players. Rising healthcare awareness and increasing adoption of innovative cardiovascular treatments are opening new avenues.

2. Regulatory Approvals and Pipeline Expansion:

Increased clinical trials and regulatory approvals are enabling more products to enter the market, providing patients and physicians with a broader range of treatment options.

Market by System Type Insights:

Polymer-based biodegradable stents held the largest share in 2023. These stents are widely adopted due to their superior biocompatibility and controlled degradation properties. The segment is expected to maintain its dominance, supported by continuous R&D efforts aimed at enhancing radial strength and drug delivery efficiency.

Magnesium-based stents, although in early adoption phases, are anticipated to witness the highest growth rate owing to their favorable degradation profiles and promising trial outcomes.

Market by End-use Insights:

Hospitals accounted for the largest end-use segment in 2023, contributing to more than 45% of global revenues. Hospitals remain the primary channel for stent placement surgeries, especially in acute cardiovascular interventions. The segment is likely to sustain its lead, supported by expanding surgical capacities and improved reimbursement networks.

Ambulatory surgical centers (ASCs) are expected to experience robust growth, driven by cost-effectiveness, reduced hospital stays, and growing acceptance of outpatient stenting procedures.

Market by Regional Insights:

North America dominated the global biodegradable stents market in 2023, driven by high disease prevalence, strong R&D investments, favorable reimbursement frameworks, and early adoption of advanced medical technologies.

Asia-Pacific is expected to register the highest CAGR during the forecast period, propelled by rapid urbanization, increasing healthcare access, and growing government initiatives to reduce the cardiovascular disease burden in countries like China and India.

Competitive Scenario:

Leading players in the Global Biodegradable Stents Market include Abbott Laboratories, Biotronik SE & Co. KG, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., Amaranth Medical, Arterius Limited, and REVA Medical. Companies are investing heavily in R&D, product pipeline expansion, and strategic partnerships to stay competitive in this dynamic market.

Key Developments:

In 2023, Abbott received FDA breakthrough designation for its next-gen bioresorbable vascular scaffold designed for improved vascular healing.

In 2024, Biotronik launched clinical trials across Europe to test its new magnesium-based stent with optimized degradation timelines.

In 2025, Elixir Medical announced a partnership with Asian distributors to expand its biodegradable stent footprint across emerging healthcare markets.

Scope of Work – Global Biodegradable Stents Market

Report Metric Details

Market Size (2023) USD 412 million

Projected Market Size (2031) USD 1,030 million

CAGR (2023–2031) 12.2%

Market Segments By System Type (Polymer-based, Magnesium-based), By End-use (Hospitals, Ambulatory Surgical Centers), By Region

Growth Drivers Increasing cardiovascular disease burden, demand for minimally invasive procedures, innovation in biodegradable materials

Opportunities Expansion in emerging markets, regulatory approvals, outpatient surgical growth

FAQs:

1) What is the current market size of the Global Biodegradable Stents Market?

The market size in 2023 is valued at USD 412 million.

2) What is the major growth driver of the Global Biodegradable Stents Market?

The major growth driver is the increasing incidence of cardiovascular diseases and the shift toward minimally invasive treatment options.

3) Which is the largest region during the forecast period in the Global Biodegradable Stents Market?

North America holds the largest regional share due to advanced healthcare systems and early technology adoption.

4) Which segment accounted for the largest market share in the Global Biodegradable Stents Market?

The Polymer-based biodegradable stents segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Biodegradable Stents Market?

Key players include Abbott Laboratories, Biotronik, Elixir Medical Corporation, Kyoto Medical Planning, and REVA Medical.